[1] | Lawrence, T. – Fong, C: The resolution of inflammation: anti-inflammatory roles for NF-κB. International Journal of Biochemistry & Cell Biology, 42, 2010, pp. 519-523. |
|
[2] | Bellik, Y. – Hmmoudi, S. M. – Abdellah, F. – Iguer-Ouada, M. – Boukraa, L.: Phytochemicals to prevent inflammation and allergy. Recent Patents on Inflammation & Allergy Drug Discovery, 6, 2012, pp. 147-158. |
|
[3] | Hsing, C. H. – Wang, J. J.: Clinical implication of perioperative inflammatory cytokine alteration. Acta Anaesthesiol Taiwanica, 53, 2015, pp. 23-28. |
|
[4] | Arnold, K. M. – Opdenaker, L. M. – Flynn, D. – Sims-Mourtada, J.: Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth & Metastasis, 8, 2015, pp. 1-13. |
|
[5] | Solov'eva, T. – Davydova, V. – Lrasikova, I. – Yermak, I.: Marine compounds with therapeutic potential in gram-negative sepsis. Marine Drugs, 11, 2013, pp. 2216-2229. |
|
[6] | Martich, G. D. – Boujoukos, A. J. – Suffredini, A. F.: Response of man to endotoxin. Immunology, 187, 1993, pp. 403-146. |
|
[7] | Cani, P. D. – Osto, M. – Geurts, L. – Everard, A.: Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes, 3, 2012, pp. 279-288. |
|
[8] | Shih, M. F. – Chen, L. Y. – Tsai, P. J. – Cherng J. Y.: In vitro and in vivo therapeutics of beta-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice. International Journal of Immunopathology & Pharmacology, 25, 2012, pp. 39-48. |
|
[9] | Lawrence, T.: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology [online] , 1(6), 7 October 2009, [cit. 2 May 2018]. |
|
[10] | Sen, R. – Smale, S. T.: Selectivity of the NF-{kappa}B response. Cold Spring Harbor Perspeictives in Biology [online], 2(4), 14 October 2009. [cit. 1 May 2018]. |
|
[11] | Bonizzi, G. – Karin, M.: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trands in Immunology, 25, 2004, pp. 280-288. |
|
[12] | Yoon, W. J. – Lee, H. J. – Kang, G. J. – Kang, H. K. – Yoo, E. S.: Inhibitory effects of Ficus erecta leaves on osteoporotic factors in vitro. Archieves of Pharmacal Research, 30, 2007, pp. 43-49. |
|
[13] | Park, S.H. – Oh, T. H. – Kim, S. S. – Kim, J. E. – Lee, S. J. – Lee, N.H.: Constituents with tyrosinase inhibitory activities from branches of Ficus erecta var, sieboldii King. Journal of Enzyme Inhibition & Medicinal Chemistry, 27, 2012, pp. 390-394. |
|
[14] | Lim, J. D. – Lee, S. R. – Kim, T. – Jang, S. A. – Kang, S. C. – Koo, H. J. – Sohn, E. – Bak, J. P. – Namkoong, S. – Kim, H.K. – Song, I. S. – Kim, N. – Sohn, E. H. – Han, J.: Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells. Marine Drugs, 13, 2015, pp. 1051-1067. |
|
[15] | Koo, H. J. – Yoon, W. J. – Sohn, E. H. – Ham, Y. M. – Jang, S. A. – Kwon, J. E. – Jeong, Y. J. – Kwak, J. H. – Sohn, E. – Park, S. Y. – Jang, K. H. – Namkoong, S. – Han, H. S. – Jung, Y. H. – Kang, S. C.: The analgesic and anti-inflammatory effects of Litsea japonica fruit are mediated via suppression of NF-kappaB and JNK/p38 MAPK activation. International Immunopharmacology, 22, 2014, pp. 84-97. |
|
[16] | Livak, K. J. – Schmittgen, T. D.: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 2001, pp. 402-408. |
|
[17] | Li, X. – Ellman, M. – Muddasani, P. – Wang, J. H. C. – Cs-Szabo, G. – van Wijnen, A. J. – Im, H. -J.: Prostaglandin E2 and it cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis, Arthritis & Rheumatism, 60, 2009, pp. 513-523. |
|
[18] | Blatteis, C. M. – Li, S. – Li, Z – Feleder, C. – Perlik, V.: Cytokines. PGE2 and endotoxic fever: a re-assessment. Prostaglandins and Other Lipid Mediators, 76, 2005, pp. 1-18. |
|
[19] | Swierkosz, T. A. – Mitchell, J. A. – Warner, T. D. – Botting, R. M. – Vane, J. R.: Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. British Journal of Pharmacology, 114, 1995, pp. 1335-1342. |
|
[20] | Kim, J. B. – Han, A. R. – Park, E. Y. – Kim, J. Y. – Cho, W. – Lee, J. – Seo, E. K. – Lee, T. K.: Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells. Biological & Pharmaceutical bulletin, 30, 2007, pp. 2345-2351. |
|
[21] | Chen, C. C.: Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Current Pharmaceutical Design, 12, 2006, pp. 3497-3508. |
|
[22] | Lawrence, T. – Willoughby, D. A. – Gilroy, D. W.: Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nature Reviews. Immunology. 2, 2002, pp. 787-795. |
|
[23] | Jung, H. J. – Park, H. J. – Kim, R. G. – Shin, K. M. – Ha, J. – Choi, J. W. – Kim, H. J. – Lee, Y. S. – Lee, K. T.: In vivo anti-inflammatory and antinociceptive effects of liriodendrin isolated from the stem bark of Acanthopanax senticosus. Planta Medica, 69, 2003, pp. 610-616. |
|